The global companion animal healthcare market is fragmented. The main competitive factors among vendors are new technologies and new product offerings. Vendors are adopting various strategies to increase their market shares and remain competitive in the market. Some of the major strategies adopted by them are M&A, distribution through partnerships, participation in medical trade shows, and product development through the use of advanced technologies. In addition, Companies are compelled to maintain a competitive advantage while also providing economic value to customers and addressing unmet requirements. For instance, in April 2020, to expand its offering of pet care diagnostics, US-based Heska corporation acquired CVM Diagnostico Veterinario, S.L., and CVM Ecografa, S.L. in Spain to strengthen its animal healthcare diagnostics business in Spain, fostering further the growth of the global companion healthcare market during the forecast period.
The vendors included in the global companion animal healthcare market are Merck and Co. Inc., Ceva Sante Animale, Zoetis Inc., C. H. Boehringer Sohn AG and Co. KG, Virbac Group, IDEXX Laboratories Inc., Indian Immunologicals Ltd., Bayer AG, Heska Corp., Dechra Pharmaceuticals Plc, Vetoquinol SA, Elanco Animal Health Inc., Agrolabo Spa, Chanelle Pharma Group, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Norbrook Laboratories Ltd., Inovet, Endovac Animal Health, and Eco Animal Health Group Plc.
Factors such as rising pet ownership, marketing campaigns and packaging innovations, and the growing prevalence of zoonotic diseases will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The companion animal healthcare market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Request Sample Report Here
Companion Animal Healthcare Market 2022-2026: Segmentation
The market is segmented as follows:
- Product
- Pharmaceuticals
- Diagnostics
The pharmaceuticals segment accounted for the largest share of the market in 2021. The rise in pet ownership, rising zoonotic disease incidence, and the rising demand for pet insurance are driving the growth of the segment.
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
North America is the major market, occupying 43% of the global market share. The growth of the regional market can be attributed to various factors such as the presence of a well-established base of animal health industries, the high adoption of companion animals, the rising incidence of parasitic infections, the growing pool of veterinarians, and the growing expenditure on animal health.
The report also covers the following areas:
Companion Animal Healthcare Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist companion animal healthcare market growth during the next five years
- Estimation of the companion animal healthcare market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the companion animal healthcare market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of companion animal healthcare market vendors
Related Reports:
Companion Animal Healthcare Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.25% |
Market growth 2022-2026 |
USD 9.82 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.65 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Agrolabo Spa, Bayer AG, C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX Laboratories Inc., Indian Immunologicals Ltd., Inovet, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Pharmaceuticals - Market size and forecast 2021-2026
- Exhibit 28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
- 5.4 Diagnostics - Market size and forecast 2021-2026
- Exhibit 32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Bayer AG
- Exhibit 85: Bayer AG - Overview
- Exhibit 86: Bayer AG - Business segments
- Exhibit 87: Bayer AG - Key offerings
- Exhibit 88: Bayer AG - Segment focus
- 10.4 C. H. Boehringer Sohn AG and Co. KG
- Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
- Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
- Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
- Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
- Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
- 10.5 Ceva Sante Animale
- Exhibit 94: Ceva Sante Animale - Overview
- Exhibit 95: Ceva Sante Animale - Product / Service
- Exhibit 96: Ceva Sante Animale - Key offerings
- 10.6 Dechra Pharmaceuticals Plc
- Exhibit 97: Dechra Pharmaceuticals Plc - Overview
- Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
- Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
- Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
- 10.7 Heska Corp.
- Exhibit 101: Heska Corp. - Overview
- Exhibit 102: Heska Corp. - Business segments
- Exhibit 103: Heska Corp. - Key news
- Exhibit 104: Heska Corp. - Key offerings
- Exhibit 105: Heska Corp. - Segment focus
- 10.8 IDEXX Laboratories Inc.
- Exhibit 106: IDEXX Laboratories Inc. - Overview
- Exhibit 107: IDEXX Laboratories Inc. - Business segments
- Exhibit 108: IDEXX Laboratories Inc. - Key news
- Exhibit 109: IDEXX Laboratories Inc. - Key offerings
- Exhibit 110: IDEXX Laboratories Inc. - Segment focus
- 10.9 Indian Immunologicals Ltd.
- Exhibit 111: Indian Immunologicals Ltd. - Overview
- Exhibit 112: Indian Immunologicals Ltd. - Product / Service
- Exhibit 113: Indian Immunologicals Ltd. - Key offerings
- 10.10 Merck and Co. Inc.
- Exhibit 114: Merck and Co. Inc. - Overview
- Exhibit 115: Merck and Co. Inc. - Business segments
- Exhibit 116: Merck and Co. Inc. - Key news
- Exhibit 117: Merck and Co. Inc. - Key offerings
- Exhibit 118: Merck and Co. Inc. - Segment focus
- 10.11 Virbac Group
- Exhibit 119: Virbac Group - Overview
- Exhibit 120: Virbac Group - Business segments
- Exhibit 121: Virbac Group - Key news
- Exhibit 122: Virbac Group - Key offerings
- Exhibit 123: Virbac Group - Segment focus
- 10.12 Zoetis Inc.
- Exhibit 124: Zoetis Inc. - Overview
- Exhibit 125: Zoetis Inc. - Business segments
- Exhibit 126: Zoetis Inc. - Key news
- Exhibit 127: Zoetis Inc. - Key offerings
- Exhibit 128: Zoetis Inc. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources
- 11.5 List of abbreviations
- Exhibit 135: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article